LIRUM THERAPEUTICS, INC.

Profile

Company Names

LIRUM THERAPEUTICS, INC.

Addresses

590 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY 10022

Phone Numbers

917-376-2350

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$6,300,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-02-08 
$6,300,000.00 
$10,000,000.00 
$3,700,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
IVAN 
 
BERGSTEIN 
DIRECTOR
STEMLINE THERAPEUTICS INC   |  LIRUM THERAPEUTICS, INC.
KENNETH 
 
HOBERMAN 
EXECUTIVE OFFICER, DIRECTOR
CENTRY PHARMA, INC.   |  NUVECTIS PHARMA, INC.   |  LIRUM THERAPEUTICS, INC.
DANIEL 
 
HUME 
DIRECTOR
LIRUM THERAPEUTICS, INC.   |  AMBERLEY HOUSE HOLDINGS LLC   |  BATAVIA INVESTMENT HOLDINGS, LLC   |  WASHINGTON MCGREGOR HOLDINGS, LLC   |  CYPRESS WAY HOLDINGS, LLC
MARK 
 
SARD 
DIRECTOR
LIRUM THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
THINKEQUITY LLC
20996